---
title: "Amrutanjan Health Care Ltd (AMRUTANJAN) — Share Price, Financials & Analysis"
symbol: "AMRUTANJAN"
company: "Amrutanjan Health Care Ltd"
canonical: "https://tapetide.com/stocks/AMRUTANJAN"
isin: "INE098F01031"
nse_symbol: "AMRUTANJAN"
bse_code: "590006"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 1410.12
generated_at: "2026-09-13T18:59:18.877Z"
---

# Amrutanjan Health Care Ltd (AMRUTANJAN)

Canonical page: https://tapetide.com/stocks/AMRUTANJAN

## Company

- **NSE Symbol:** AMRUTANJAN
- **BSE Code:** 590006
- **ISIN:** INE098F01031
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2015-01-02
- **CEO:** Mr. Sambhu Prasad Sivalenka
- **Employees:** 737
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** amrutanjan.com

## About

AHCL has been manufacturing ayurvedic balm for pain management since 1893, and is currently managed by the third-generation of promoters. The company is more than 120 years old and is into OTC products in the segments of pain management, women's hygiene, and packaged fruit juice drink.  [1]

## Latest Price

- **Price:** ₹490.95
- **Change:** +0.6 (+0.12%)
- **Open:** ₹492
- **Day High:** ₹498
- **Day Low:** ₹485.05
- **Previous Close:** ₹490.35
- **Volume:** 73521
- **As Of:** 2026-09-11T09:59:51+00:00

## Key Fundamentals

Observed at 2026-09-11T04:53:47.932229Z.

- **Market Cap:** ₹1410.12 Cr
- **Classification:** Microcap
- **P/E (reported):** 26.5
- **P/E (TTM):** 26.3
- **EPS (TTM):** ₹18.67
- **EPS (reported):** ₹15.56
- **Book Value:** ₹128.06
- **Price to Book:** 3.86
- **Dividend Yield:** 1%
- **ROE:** 18.92%
- **ROCE:** 29.24%
- **Debt to Equity:** 0.01
- **Revenue (yearly):** ₹192.4 Cr
- **Net Income:** ₹20.6 Cr
- **EBITDA:** ₹36.5 Cr
- **52-Week High:** ₹774.3
- **52-Week Low:** ₹482.8
- **RSI (14):** 40.17

## Tapetide Score

- **Score:** 51 / 100
- **Score date:** 2026-09-04
- **Archetype:** No Dominant Pattern
- **What it means:** The three pillars do not combine into a recognisable pattern. Read them individually rather than looking for one story — the lack of a pattern is itself the finding.
- **Pillar profile:** Quality: Average · Valuation: Fair · Momentum: Falling
- **Percentile:** 52 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 83.8 | 9% |
| growth | 39.33 | 9% |
| momentum | 23.91 | 12% |
| ownership | 48.77 | 24% |
| quality | 59.4 | 22% |
| valuation | 53.87 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 26.7%
- Company's working capital requirements have reduced from 122 days to 93.8 days

### Weaknesses

- The company has delivered a poor sales growth of 8.59% over past five years.
- Promoter holding has decreased over last 3 years: -3.51%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 13.01% | — | — |
| ebitda margin growth | -64.76% | 15.48% | — | — |
| net income growth | -72.84% | 38.26% | 17% | 1% |
| revenue growth | -30.87% | 12.51% | 10% | 9% |
| roce | -71% | 15.3% | — | — |
| roe | -73.01% | 20.51% | — | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 99.31 | 116.99 | 127.06 | 83.74 | 109.92 | 122.75 | 135.41 | 94.05 | 117.7 | 141.04 | 149.77 | 102.97 |
| Expenses | 92.47 | 95.42 | 110.82 | 80.19 | 96.32 | 99.4 | 117.71 | 85.61 | 101.18 | 115.87 | 124.22 | 96.73 |
| Operating Profit | 6.84 | 21.57 | 16.24 | 3.55 | 13.6 | 23.35 | 17.7 | 8.44 | 16.52 | 25.17 | 25.55 | 6.24 |
| OPM % | 6.89 | 18.44 | 12.78 | 4.24 | 12.37 | 19.02 | 13.07 | 8.97 | 14.04 | 17.85 | 17.06 | 6.06 |
| Other Income | 3.95 | 3.76 | 4.95 | 4.45 | 4.05 | 4.36 | 4.82 | 4.43 | 4.3 | 2.87 | -2.88 | 1.78 |
| Interest | 0.03 | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 |
| Depreciation | 1.55 | 1.58 | 1.53 | 1.59 | 1.65 | 1.66 | 1.62 | 1.53 | 1.56 | 1.62 | 1.61 | 1.92 |
| Profit before tax | 9.21 | 23.7 | 19.61 | 6.35 | 15.94 | 25.99 | 20.86 | 11.29 | 19.21 | 26.37 | 21.01 | 6.06 |
| Tax % | 25.62 | 26.41 | 30.34 | 27.24 | 25.97 | 25.93 | 27.23 | 26.4 | 27.33 | 26.2 | 22.94 | 28.05 |
| Net Profit | 6.85 | 17.45 | 13.66 | 4.62 | 11.8 | 19.25 | 15.18 | 8.31 | 13.96 | 19.45 | 16.19 | 4.37 |
| EPS in Rs | 2.37 | 6.04 | 4.72 | 1.6 | 4.08 | 6.66 | 5.25 | 2.87 | 4.83 | 6.73 | 5.6 | 1.51 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 220 | 253 | 261 | 333 | 406 | 380 | 421 | 452 | 503 | 511 |
| Expenses | 192 | 222 | 231 | 258 | 326 | 335 | 369 | 394 | 427 | 438 |
| Operating Profit | 28 | 31 | 31 | 75 | 80 | 45 | 52 | 58 | 76 | 73 |
| OPM % | 13 | 12 | 12 | 22 | 20 | 12 | 12 | 13 | 15 | 14 |
| Other Income | 8 | 7 | 8 | 11 | 15 | 15 | 16 | 18 | 9 | 6 |
| Interest | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 4 | 4 | 4 | 5 | 6 | 7 | 6 | 7 |
| Profit before tax | 33 | 35 | 34 | 82 | 91 | 54 | 62 | 69 | 78 | 73 |
| Tax % | 39 | 29 | 27 | 25 | 26 | 26 | 27 | 26 | 26 | — |
| Net Profit | 20 | 25 | 25 | 61 | 67 | 40 | 45 | 51 | 58 | 54 |
| EPS in Rs | 6.84 | 8.39 | 8.58 | 20.93 | 22.99 | 13.63 | 15.55 | 17.58 | 20.03 | 18.67 |
| Dividend Payout % | 22 | 26 | 24 | 20 | 20 | 34 | 30 | 26 | 24 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves | 113 | 126 | 143 | 156 | 213 | 262 | 288 | 286 | 324 | 367 |
| Borrowings | 2 | 0 | 0 | 2 | 1 | 1 | 1 | 2 | 2 | 2 |
| Other Liabilities | 34 | 38 | 42 | 44 | 57 | 84 | 70 | 77 | 93 | 137 |
| Total Liabilities | 152 | 166 | 188 | 205 | 274 | 350 | 362 | 367 | 421 | 509 |
| Fixed Assets | 27 | 28 | 26 | 26 | 23 | 28 | 49 | 50 | 49 | 51 |
| CWIP | 1 | 0 | 0 | 0 | 2 | 17 | 1 | 2 | 16 | 106 |
| Investments | 10 | 8 | 18 | 18 | 18 | 13 | 5 | 0 | 0 | 3 |
| Other Assets | 115 | 131 | 144 | 161 | 232 | 291 | 307 | 315 | 356 | 349 |
| Total Assets | 152 | 166 | 188 | 205 | 274 | 350 | 362 | 367 | 421 | 509 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 8 | 19 | 21 | 18 | 91 | 52 | 20 | 28 | 51 | 36 |
| Cash from Investing Activity | 0 | -8 | -11 | -14 | -88 | -36 | -2 | 19 | -31 | -21 |
| Cash from Financing Activity | -5 | -9 | -7 | -12 | -7 | -17 | -15 | -48 | -13 | -14 |
| Net Cash Flow | 3 | 2 | 3 | -7 | -4 | -1 | 3 | -1 | 6 | 1 |
| Free Cash Flow | 5 | 18 | 19 | 16 | 89 | 29 | 11 | 21 | 15 | -19 |
| CFO/OP | 77 | 105 | 101 | 95 | 146 | 96 | 81 | 86 | 118 | 72 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 51 | 46 | 47 | 37 | 19 | 34 | 32 | 42 | 45 | 44 |
| Inventory Days | 44 | 40 | 45 | 74 | 45 | 53 | 58 | 50 | 45 | 56 |
| Days Payable | 110 | 102 | 92 | 98 | 106 | 122 | 95 | 96 | 113 | 106 |
| Cash Conversion Cycle | -15 | -16 | 0 | 13 | -41 | -35 | -6 | -5 | -23 | -6 |
| Working Capital Days | 76 | 26 | 30 | 70 | 28 | 92 | 117 | 173 | 99 | 94 |
| ROCE % | 28 | 25 | 25 | 23 | 44 | 38 | 19 | 21 | 22 | 25 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 50.59% | 50.59% | 50.59% | 50.59% | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% |
| FIIs | 0.75% | 0% | 1.38% | 1.55% | 2.34% | 2.3% | 2.3% | 2.41% | 2.38% | 2.27% | 2.17% | 2.44% |
| DIIs | 7.1% | 6.88% | 7.29% | 7.32% | 10.6% | 11.12% | 11.41% | 12.7% | 12.9% | 13% | 12.66% | 12.28% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 35% | 34.61% | 34.17% | 33.87% | 34.09% | 33.73% | 33.56% | 32.28% | 32.18% | 32.09% | 32.2% | 32.06% |
| Others | 6.57% | 7.92% | 6.57% | 6.67% | 6.45% | 6.33% | 6.22% | 6.09% | 6.02% | 6.13% | 6.45% | 6.7% |
| No. of Shareholders | 72002 | 68404 | 62664 | 57169 | 54536 | 53856 | 51674 | 49431 | 47954 | 46675 | 45805 | 45135 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 3 / 4 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 500.97 | Sell |
| EMA (10) | 501.16 | Sell |
| SMA (20) | 507.55 | Sell |
| EMA (20) | 506.04 | Sell |
| SMA (50) | 517.44 | Sell |
| EMA (50) | 517.05 | Sell |
| SMA (100) | 536.86 | Sell |
| EMA (100) | 534.42 | Sell |
| SMA (200) | 571.59 | Sell |
| EMA (200) | 566.28 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 39.12 | Neutral |
| MACD (12,26,9) | -6.04 | Sell |
| Stochastic (14,3,3) | 11.26 | Buy |
| ADX (14) | 14.21 | Neutral |
| Williams %R (14) | -88.43 | Buy |
| ATR (14) | 16.26 | High Volatility |
| ROC (12) | -6.97 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 39.97 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-28 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3b390f6-54f6-45d9-8d3b-5fe9e21a6a31.pdf) |
| 2026-08-28 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12b3f4a0-ab6a-41e0-8c3c-f29538e91cf2.pdf) |
| 2026-08-12 | [Investor Presentation For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5772b7b3-d6f4-419f-bd5a-16fdc631b6df.pdf) |
| 2026-08-11 | [Board Meeting Outcome for Financial Results And Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ce34ff7-fbee-4b01-8f01-48205d44299c.pdf) |
| 2026-08-11 | [Record Date For The Final Dividend And AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58e8150f-3118-4b9e-adbe-7e1c0a16c433.pdf) |
| 2026-08-06 | [Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=925699d4-5b0c-413d-8faa-72de27560f3b.pdf) |
| 2026-08-05 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=B33C2815_E993_428D_82FA_349555F2D12C_103616.pdf) |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Credit Rating](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55f535fd-6f64-482d-b12c-1a855061fa09.pdf) |
| 2026-08-05 | [Commissioning Of New Manufacturing Facility](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c2c1304-7bfe-44f9-9842-d15ed4623081.pdf) |
| 2026-08-05 | [Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6cf9ccea-8eb8-49ef-9724-aafe47c96566.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 May - Board approved revised ESOP Phase 2 for 44 employees; 2,00,000 shares over FY27-FY31 at Rs. 502. | [Intimation On Rolling Out Of The Revised Second Phase 'ESOP 2' Of The Existing ESOP Scheme Of The Company By The Name Of 'Amrutanjan Health Care Limited - Employees Stock Option Scheme 2020'. 8 May - Board approved revised ESOP Phase 2 for 44 employees; 2,00,000 shares over FY27-FY31 at Rs. 502.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1ba4db08-73eb-4a90-b8c7-7aefa8773e1b.pdf) |
| 8 May - Board appointed Ramaswami Krishnan as independent director and reappointed Muralidharan Swayambunathan for five years. | [Announcement under Regulation 30 (LODR)-Change in Management 8 May - Board appointed Ramaswami Krishnan as independent director and reappointed Muralidharan Swayambunathan for five years.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/38e83635-2a85-48d4-bdac-fe5eca7e83f2.pdf) |
| 8 May - Audited FY26 results approved; Rs 2.90 final dividend recommended; two independent director changes and ESOP revision. | [Board Meeting Outcome for Outcome Of Board Meeting 8 May - Audited FY26 results approved; Rs 2.90 final dividend recommended; two independent director changes and ESOP revision.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/d6863e4b-1dc7-4b8e-b53b-fc2ccc39c6db.pdf) |
| 8 May - Amrutanjan approved appointment of Ramaswami Krishnan and reappointment of Muralidharan Swayambunathan as independent directors. | [Announcement under Regulation 30 (LODR)-Change in Management 8 May - Amrutanjan approved appointment of Ramaswami Krishnan and reappointment of Muralidharan Swayambunathan as independent directors.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/e73ad15e-4edb-4896-bdf2-7cd728b7b236.pdf) |
| 8 Jan - Certificate under Reg.74(5) for quarter ended 31/12/2025 by RTA Cameo confirming dematerialisation. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Jan - Certificate under Reg.74(5) for quarter ended 31/12/2025 by RTA Cameo confirming dematerialisation.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/aef488f7-dcbc-495f-8e8a-e51216e845d9.pdf) |
| 8 Apr - Submitted Regulation 74(5) compliance certificate for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr - Submitted Regulation 74(5) compliance certificate for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fbd39e2f-e39f-48b1-9396-37e55c29c307.pdf) |
| 30 Apr - Board meets on 8 May 2026 to approve FY26 audited results and consider final dividend. | [Board Meeting Intimation for Board Meeting Intimation For Audited Financial Results For The Quarter And Year Ended 31 March 2026 Recommendation Of Final Dividend For The Year 2025-26 30 Apr - Board meets on 8 May 2026 to approve FY26 audited results and consider final dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7d4149a1-5920-42f4-aa3d-d2629f83b8e7.pdf) |
| 30 Apr - Board meets on 8 May 2026 to approve FY26 audited results and consider final dividend. | [Board Meeting Intimation for Board Meeting Intimation For Audited Financial Results For The Quarter And Year Ended 31 March 2026 Recommendation Of Final Dividend For The Year 2025-26 30 Apr - Board meets on 8 May 2026 to approve FY26 audited results and consider final dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/7d4149a1-5920-42f4-aa3d-d2629f83b8e7.pdf) |
| 3 Feb - Unaudited Q3 and nine-month results to Dec 31, 2025; interim dividend Re.1/share (INR289.11 lakh). | [Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025. 3 Feb - Unaudited Q3 and nine-month results to Dec 31, 2025; interim dividend Re.1/share (INR289.11 lakh).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b7a4843a-ecf6-499b-8ec9-f5c0ba0cf36f.pdf) |
| 2d - Investor Presentation for the Quarter and year ended 31st March 2026 | [Announcement under Regulation 30 (LODR)-Investor Presentation 2d - Investor Presentation for the Quarter and year ended 31st March 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/e52a9993-9750-4970-accf-b487892406be.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-05-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e52a9993-9750-4970-accf-b487892406be.pdf) |
| 2025-08-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94ad9121-9750-47f5-8bfe-8653285e1690.pdf) |
| 2025-02-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78500952-eecd-4878-bb69-5885bd430ace.pdf) |
| 2024-11-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9362534-324b-46e6-911f-75d3668f7dd6.pdf) |
| 2024-08-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04e2e363-04b2-4ceb-a501-b1930225fd85.pdf) |
| 2024-05-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69ead270-84c4-4418-acf7-4f51739b8da8.pdf) |
| 2024-02-10 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6c92df3-eefe-4ad8-9931-4987b204c819.pdf) |
| 2023-11-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f06ef9da-8b36-4b17-94ef-87c050405791.pdf) |
| 2023-08-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e651473-dacf-4274-b89c-af168e297f6d.pdf) |
| 2023-06-01 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a042c092-e36c-4e7a-a3de-70363d8e0497.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/adfd1b4c-9c93-446e-a680-a6177b41e635.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/SUNDARMFIN_03112025145105_Investor_presentation.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c9362534-324b-46e6-911f-75d3668f7dd6.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f06ef9da-8b36-4b17-94ef-87c050405791.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e77e3345-d1f8-4cc3-b8f2-c00facda2890.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cf98bdf7-a22e-477d-b48d-e7f6abc160b5.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b0c69c9-e12b-4196-881b-5e6da7fd9a94.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8b0c69c9-e12b-4196-881b-5e6da7fd9a94.pdf) |
| Nov 2019 | [Concall - Nov 2019](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5ed4ef5-6f3f-4f21-aec0-c4baecd35696.pdf) |
| Nov 2019 | [Concall - Nov 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f5ed4ef5-6f3f-4f21-aec0-c4baecd35696.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2025-02-12 | [Unaudited Financial Results For The Quarter Ended December 31 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7f9e08a-2a7c-4a8a-bb89-192ab10d2ed3.pdf) |
| 2024-11-12 | [Unaudited Financial Results - 30.09.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7b05aaa-b7d9-4545-bfe2-617d15ce09ea.pdf) |
| 2024-08-13 | [Unaudited Financial Results For The Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03b5c922-0af3-40e2-a99f-1c45e8b838f6.pdf) |
| 2024-05-23 | [Financial Results For The Year Ended 31.03.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da408509-8bc7-4649-b682-32abfd2ce5d8.pdf) |
| 2024-02-09 | [Financial Result For The Quarter Ended December 31, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c1246fd-df9e-41b3-82a2-37f0a5e0fc48.pdf) |
| 2023-11-10 | [Outcome Of The Board Meeting Held On 10-11-2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a106abfb-4323-4930-9623-4d04afbdc44c.pdf) |
| 2023-11-10 | [Board Meeting Outcome for Outcome Of The Board Meeting Held On November 10, 2023 Approving The Unaudited Financial Results For The Quarter/Half Year Ended 30Th September 2023 And Declaration Of First Interim Dividend For The FY 2023-24](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c8fcf44-8a36-4cf6-9937-f45cf87e0590.pdf) |
| 2023-08-02 | [Board Meeting Outcome for Outcome Of The Board Meeting- Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (SEBI LODR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3acf95c0-3623-46b9-a73e-4753d3bb4073.pdf) |
| 2023-08-02 | [Outcome Of The Board Meeting- Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (SEBI LODR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd4ee423-cc30-449b-a104-045aeab36b64.pdf) |
| 2023-05-30 | [Board Meeting Outcome for Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a301138e-ec4c-4734-8a51-1a54eb9a9744.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/86d21731-6665-4696-bc1b-c73126337e9e.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/67f5ca7e-b7ea-4b06-be26-ed9c96fdc0ba.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a2d68dc9-2ad7-4191-8010-d1d4eff77322.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/590006/74741590006.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/590071/73442590071.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/590006/70249590006.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/590006/65361590006.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/590006/5900060319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/590006/5900060318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/590006/5900060317.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:59:18.877Z.